These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 9376765
1. [The neurochemical profile of the septal nucleus accumbens in the anxiolytic action of tranquilizers on different models of anxiety]. Talalaenko AN, Panfilov VIu, Vozdigan SA, Pokramovich AI, Markova OP, Okhrimenko SV. Eksp Klin Farmakol; 1997; 60(4):7-9. PubMed ID: 9376765 [Abstract] [Full Text] [Related]
2. [The neurochemical profile of the caudate nucleus in the anxiolytic action of benzodiazepine and nonbenzodiazepine tranquilizers on different models of anxiety]. Talalaenko AN, Gordienko DV, Markova OP. Eksp Klin Farmakol; 2000; 63(1):14-8. PubMed ID: 10763103 [Abstract] [Full Text] [Related]
3. [The neurochemical mechanisms of the central amygdaloid nucleus and the anxiolytic action of tranquilizers in different models of anxiety states]. Talalaenko AN, Krivobok GK, Babiĭ IuV, Bogdanov VA, Perch NN. Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(6):1116-23. PubMed ID: 7879435 [Abstract] [Full Text] [Related]
4. [The characteristics of the anxiolytic action of benzodiazepine and non-benzodiazepine tranquilizers in different tests of anxiety]. Talalaenko AN, Abramets II, Stakhovskiĭ IuV, Shekhovtsov AA, Shevchenko SL, Chernikov AV. Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):144-51. PubMed ID: 1349783 [Abstract] [Full Text] [Related]
5. [Neurochemical features of the ventral pallidum in realization of the antiaversive effects of anxiolytics in different models of anxiety]. Talalaenko AN, Pankrat'ev DV, Bulgakova NP. Eksp Klin Farmakol; 2006; 69(1):6-11. PubMed ID: 16579051 [Abstract] [Full Text] [Related]
6. [The neurochemical profile of the dorsal hippocampus and the antiaversive effects of anxiolytics in different models of anxiety in rats]. Talalaenko AN. Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(3):621-6. PubMed ID: 8103252 [Abstract] [Full Text] [Related]
7. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction]. Talalaenko AN. Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232 [Abstract] [Full Text] [Related]
8. [Monoaminergic and aminoacidergic mechanisms of the posterior hypothalamus in realization of the antiaversive effects of anxiosedative and anxioselective agents in various anxiety models]. Talalaenko AN, Pankrat'ev DV, Goncharenko NV. Eksp Klin Farmakol; 2002; 65(5):22-6. PubMed ID: 12596508 [Abstract] [Full Text] [Related]
9. Repeated cocaine decreases the avoidance response to a novel aversive stimulus in rats. Sorg BA, Davidson DL, Hochstatter T, Sylvester PW. Psychopharmacology (Berl); 2002 Aug; 163(1):9-19. PubMed ID: 12185395 [Abstract] [Full Text] [Related]
10. [The role of neurochemical mechanisms of the dorsal raphe nucleus in various models of anxiety states in rats]. Talalaenko AN. Zh Vyssh Nerv Deiat Im I P Pavlova; 1989 Aug; 39(6):1124-8. PubMed ID: 2576490 [Abstract] [Full Text] [Related]
11. [The mechanisms of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives, serotonin agonists]. Talalaenko AN, Kharin NA. Eksp Klin Farmakol; 1993 Aug; 56(2):11-3. PubMed ID: 8102289 [Abstract] [Full Text] [Related]
12. [Monoamine, GABA, and glutamergic mechanisms of the anterior hypothalamus in anti-aversive effects of sedative and selective drugs in various models of anxiety]. Talalaenko AN, Gordienko DV, Markova OP, Goncharenko NV, Pankrat'ev DV. Eksp Klin Farmakol; 2001 Aug; 64(2):20-4. PubMed ID: 11548441 [Abstract] [Full Text] [Related]
13. [The functional role of monoaminergic and amino acid-ergic mechanisms of the locus coeruleus in anxiety from different aversive origins]. Talalaenko AN, Stakhovskiĭ IuV, Bogdanov BA, Babiĭ IuV, Perch NN. Biull Eksp Biol Med; 1993 Jun; 115(6):634-6. PubMed ID: 8104050 [Abstract] [Full Text] [Related]
14. [Neurochemical mechanisms of dorsal pallidum in antiadverse effects of anxiolytics of different models of anxiety]. Talaenko AN, Krivobok GK, Pankrat'ev DV, Goncharenko NV. Ross Fiziol Zh Im I M Sechenova; 2005 Jul; 91(7):776-84. PubMed ID: 16206621 [Abstract] [Full Text] [Related]
15. Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety. Talalaenko AN, Pankrat'ev DV, Goncharenko NV. Neurosci Behav Physiol; 2003 Mar; 33(3):255-61. PubMed ID: 12762592 [Abstract] [Full Text] [Related]
16. Neurochemical mechanisms of the dorsal pallidum in the antiaversive effects of anxiolytics in various models of anxiety. Talalaenko AN, Krivobok GK, Pankrat'ev DV, Goncharenko NV. Neurosci Behav Physiol; 2006 Sep; 36(7):749-54. PubMed ID: 16841156 [Abstract] [Full Text] [Related]
17. GABAA and GABAB agonist microinjections into medial accumbens shell increase feeding and induce anxiolysis in an animal model of anxiety. Lopes AP, da Cunha IC, Steffens SM, Ferraz A, Vargas JC, de Lima TC, Neto JM, Faria MS, Paschoalini MA. Behav Brain Res; 2007 Dec 03; 184(2):142-9. PubMed ID: 17714798 [Abstract] [Full Text] [Related]
18. Individual differences in the effects of serotonergic anxiolytic drugs on the motivation to self-administer cocaine. Homberg JR, Arends B, Wardeh G, Raasø HS, Schoffelmeer AN, de Vries TJ. Neuroscience; 2004 Dec 03; 128(1):121-30. PubMed ID: 15450359 [Abstract] [Full Text] [Related]
19. [Neurochemical analysis of the amygdala basolateral nucleus of rats during anxiety tests]. Talalaenko AN, Babiĭ IuV, Perch NN, Vozdvigin SA, Panfilov VIu. Ross Fiziol Zh Im I M Sechenova; 1997 Mar 03; 83(3):88-94. PubMed ID: 12436687 [Abstract] [Full Text] [Related]
20. Animal models of anxiety and benzodiazepine actions. Iversen SD. Arzneimittelforschung; 1980 Mar 03; 30(5a):862-8. PubMed ID: 6106486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]